Public Sector Network Tender Alert

 

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England Offer reference number: CM/PHR/14/5446 Period of framework agreement: CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months CM/PHR/14/5446/02 - North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months South of England - 1 September 2017 - 31 August 2018 with an option to extend for up to 12 months Midlands and East - 1 September 2017 - 28 February 2019 with an option to extend for up to 18 months

Contact:

Michelle Clarke
michelle.clarke6@nhs.net
NHS England, Commercial Medicines Unit, 2nd Floor, Rutland House
Runcorn, Cheshire
WA7 2ES
England

Contract value: 710890000

Published: 30 May 2017, Receipt by: 29 Jun 2017